|
1
|
Huang TR, Zhang SW, Chen WQ, et al: Trends
in nasopharyngeal carcinoma mortality in China, 1973–2005. Asian
Pac J Cancer Prev. 13:2495–2502. 2012.PubMed/NCBI
|
|
2
|
Chan AT: Nasopharyngeal carcinoma. Ann
Oncol. 21(Suppl 7): vii308–vii312. 2010.PubMed/NCBI
|
|
3
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ren JS, Chen WQ, Shin HR, et al: A
comparison of two methods to estimate the cancer incidence and
mortality burden in China in 2005. Asian Pac J Cancer Prev.
11:1587–1594. 2010.PubMed/NCBI
|
|
5
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
King AD, Ahuja AT, Leung SF, et al: Neck
node metastases from nasopharyngeal carcinoma: MR imaging of
patterns of disease. Head Neck. 22:275–281. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang CJ, Leung SW, Lian SL, Wang CJ, Fang
FM and Ho YH: Patterns of distant metastases in nasopharyngeal
carcinoma. Kaohsiung J Med Sci. 12:229–234. 1996.PubMed/NCBI
|
|
8
|
Lim LH and Pervaiz S: Annexin 1: the new
face of an old molecule. FASEB J. 21:968–975. 2007. View Article : Google Scholar
|
|
9
|
Patel DM, Ahmad SF, Weiss DG, Gerke V and
Kuznetsov SA: Annexin A1 is a new functional linker between actin
filaments and phagosomes during phagocytosis. J Cell Sci.
124:578–588. 2011. View Article : Google Scholar
|
|
10
|
Garcia Pedrero JM, Fernandez MP, Morgan
RO, et al: Annexin A1 down-regulation in head and neck cancer is
associated with epithelial differentiation status. Am J Pathol.
164:73–79. 2004.PubMed/NCBI
|
|
11
|
Zhang L, Yang X, Zhong LP, et al:
Decreased expression of Annexin A1 correlates with pathologic
differentiation grade in oral squamous cell carcinoma. J Oral
Pathol Med. 38:362–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang LD, Yang YH, Liu Y, Song HT, Zhang LY
and Li PL: Decreased expression of annexin A1 during the
progression of cervical neoplasia. J Int Med Res. 36:665–672. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiu CC, Lin CY, Lee LY, et al: Molecular
chaperones as a common set of proteins that regulate the invasion
phenotype of head and neck cancer. Clin Cancer Res. 17:4629–4641.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng AL, Huang WG, Chen ZC, et al:
Identificating cathepsin D as a biomarker for differentiation and
prognosis of nasopharyngeal carcinoma by laser capture
microdissection and proteomic analysis. J Proteome Res.
7:2415–2426. 2008. View Article : Google Scholar
|
|
15
|
Gerke V and Moss SE: Annexins: from
structure to function. Physiol Rev. 82:331–371. 2002.PubMed/NCBI
|
|
16
|
McArthur S, Cristante E, Paterno M, et al:
Annexin A1: a central player in the anti-inflammatory and
neuroprotective role of microglia. J Immunol. 185:6317–6328. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lecona E, Barrasa JI, Olmo N, Llorente B,
Turnay J and Lizarbe MA: Upregulation of annexin A1 expression by
butyrate in human colon adenocarcinoma cells: role of p53, NF-Y,
and p38 mitogen-activated protein kinase. Mol Cell Biol.
28:4665–4674. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sakaguchi M, Murata H, Sonegawa H, et al:
Truncation of annexin A1 is a regulatory lever for linking
epidermal growth factor signaling with cytosolic phospholipase A2
in normal and malignant squamous epithelial cells. J Biol Chem.
282:35679–35686. 2007. View Article : Google Scholar
|
|
19
|
Alldridge LC and Bryant CE: Annexin 1
regulates cell proliferation by disruption of cell morphology and
inhibition of cyclin D1 expression through sustained activation of
the ERK1/2 MAPK signal. Exp Cell Res. 290:93–107. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Parente L and Solito E: Annexin 1: more
than an anti-phospholipase protein. Inflamm Res. 53:125–132. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsiang CH, Tunoda T, Whang YE, Tyson DR
and Ornstein DK: The impact of altered annexin I protein levels on
apoptosis and signal transduction pathways in prostate cancer
cells. Prostate. 66:1413–1424. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang XY, Ren CP, Wang L, et al:
Identification of differentially expressed genes in metastatic and
non-metastatic nasopharyngeal carcinoma cells by suppression
subtractive hybridization. Cell Oncol. 27:215–223. 2005.
|
|
23
|
Paweletz CP, Ornstein DK, Roth MJ, et al:
Loss of annexin 1 correlates with early onset of tumorigenesis in
esophageal and prostate carcinoma. Cancer Res. 60:6293–6297.
2000.PubMed/NCBI
|
|
24
|
Deng S, Wang J, Hou L, et al: Annexin A1,
A2, A4 and A5 play important roles in breast cancer, pancreatic
cancer and laryngeal carcinoma, alone and/or synergistically. Oncol
Lett. 5:107–112. 2013.
|
|
25
|
Yom CK, Han W, Kim SW, et al: Clinical
significance of annexin A1 expression in breast cancer. J Breast
Cancer. 14:262–268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang LP, Bi J, Yao C, et al: Annexin A1
expression and its prognostic significance in human breast cancer.
Neoplasma. 57:253–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Babbin BA, Lee WY, Parkos CA, et al:
Annexin I regulates SKCO-15 cell invasion by signaling through
formyl peptide receptors. J Biol Chem. 281:19588–19599. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng TY, Wu MS, Lin JT, et al: Annexin A1
is associated with gastric cancer survival and promotes gastric
cancer cell invasiveness through the formyl peptide
receptor/extracellular signal-regulated kinase/integrin
beta-1-binding protein 1 pathway. Cancer. 118:5757–5767. 2012.
View Article : Google Scholar
|
